TrialsgrambetaRCTs are beautiful

ESTIMABL2

2022

No Radioiodine Ablation vs. Low-Activity Radioiodine in Low-Risk Thyroid Cancer

In 730 patients with low-risk differentiated thyroid carcinoma after thyroidectomy, no radioiodine ablation was non-inferior to 1.1 GBq radioiodine plus rhTSH for event-free survival at 3 yr.

Result

Composite of functional, structural or biologic abnormalities at 3 yr
Absolute difference
0.3 points

The absolute difference is derived from the event rates.

Also reported: Non-inferiority demonstrated.

Original publication
Subtopic
Differentiated thyroid cancer
Design
Open-label non-inferiority RCT, 3 yr
Relevance
Important: one of several pillars.
Source
Leboulleux S, et al. N Engl J Med. 2022;386(10):923-932.doi 10.1056/NEJMoa2111953

Discussion & critique

Practice-changing for low-risk DTC: radioiodine can be omitted entirely after total thyroidectomy in carefully selected patients.